시장보고서
상품코드
1469129

신속 의료 진단 키트 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품별, 용도별, 최종 용도별, 지역별, 경쟁사별(2019-2029년)

Rapid Medical Diagnostic Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Over the Counter Kits, Professional Kits), By Application, By End-use Region and Competition, 2019-2029F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 신속 의료 진단 키트 시장 규모는 2023년 164억 7,000만 달러에 달할 것으로 예상되며, 2029년까지 8.87%의 CAGR로 예측 기간 동안 강력한 성장세를 보일 것으로 예상됩니다. 신속하고 정확한 진단 솔루션에 대한 수요 증가로 인해 전 세계 신속 의료 진단 키트 시장은 최근 몇 년 동안 괄목할 만한 성장과 변화를 거듭하고 있습니다. 현장 검사용으로 설계된 이 키트는 다양한 질병을 신속하게 진단할 수 있도록 도와주며, 의료 환경에서 필수적인 도구로 부상하고 있습니다. 시장 확대는 감염성 질환의 확산, 조기 발견 및 치료의 필요성, 효율적인 의료 서비스 제공에 대한 요구 등 몇 가지 주요 요인에 의해 촉진되고 있습니다. 이 시장의 주요 촉진요인 중 하나는 특히 COVID-19 팬데믹 이후 감염성 질환의 증가입니다. 항원 및 항체 검사와 같은 신속 진단 키트는 집단 검사 및 접촉자 추적 노력에 있어 매우 중요한 역할을 하고 있으며, 이는 전염병의 확산을 막는 데 있어 그 중요성을 입증하고 있습니다. 또한, 혁신적인 기술의 발전과 당뇨병 및 심혈관 질환과 같은 만성 질환의 증가로 인해 신속한 결과를 제공하는 진단 키트가 개발되어 즉각적인 의료 개입을 촉진하고 환자의 예후를 개선하고 있습니다.

세계 신속 의료 진단 키트 시장에는 임신 테스트 키트, 포도당 모니터링 키트, 감염 탐지 키트, 암 검진 키트 등 다양한 제품이 포함되어 있습니다. 이들 키트는 사용하기 쉽도록 설계되었으며, 최소한의 교육으로 몇 분 안에 결과를 얻을 수 있어 임상 및 비임상 현장에서 사용하기에 이상적인 제품입니다. 또한, 특히 팬데믹 상황에서 인기가 급증하고 있는 원격의료 및 원격진료의 확대도 시장을 주도하고 있습니다.

주요 시장 촉진요인

전염병 유행 증가

기술의 발전

세계의 고령화

주요 시장 과제

품질과 정확성에 대한 우려

비용 및 접근성

주요 시장 동향

Point of Care 검사의 보급

신속한 암 진단

부문별 인사이트

용도별 인사이트

최종 용도 인사이트

지역별 인사이트

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 신속 의료 진단 키트 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별(OTC 키트, 업무용 키트)
    • 용도별(혈당치 검사, 감염증 검사, 순환 대사 검사, 임신·불임 검사, 변잠혈 검사, 응고 검사, 독성 검사, 지질 프로파일 검사, 기타 용도)
    • 최종 용도별(병원, 외래 수술 센터, 기타)
    • 지역별
    • 기업별(2023년)
  • 시장 맵
    • 제품별
    • 용도별
    • 최종 용도별
    • 지역별

제5장 아시아태평양의 신속 의료 진단 키트 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 용도별
    • 최종 용도별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 호주
    • 일본
    • 한국

제6장 유럽의 신속 의료 진단 키트 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 용도별
    • 최종 용도별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 스페인
    • 이탈리아
    • 영국

제7장 북미의 신속 의료 진단 키트 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 용도별
    • 최종 용도별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 남미의 신속 의료 진단 키트 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 용도별
    • 최종 용도별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제9장 중동 및 아프리카의 신속 의료 진단 키트 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 용도별
    • 최종 용도별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 이집트

제10장 시장 역학

  • 성장 촉진요인
  • 과제

제11장 시장 동향과 발전

  • 최근의 동향
  • 제품 발매
  • 인수합병

제12장 신속 의료 진단 키트 세계 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제14장 경쟁 상황

  • Artron Laboratories Inc.
  • Alfa Scientific Designs, Inc.
  • BD and company
  • bioMerieux SA
  • BTNX, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Cardinal Health Inc.
  • Creative Diagnostics
  • F. Hoffmann-La Roche AG

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm 24.05.02

Global Rapid Medical Diagnostic Kits Market was valued at USD 16.47 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.87% through 2029. The Global Rapid Medical Diagnostic Kits Market has witnessed significant growth and transformation in recent years, driven by the increasing demand for quick and accurate diagnostic solutions. These kits, designed for point-of-care testing, have emerged as essential tools in healthcare settings, helping in the rapid diagnosis of various medical conditions. The market's expansion is propelled by several key factors, including the growing prevalence of infectious diseases, the need for early detection and treatment, and the desire for efficient healthcare delivery. One of the primary drivers of this market is the rise in infectious diseases, particularly evident in the wake of the COVID-19 pandemic. Rapid diagnostic kits, such as antigen and antibody tests, have played a pivotal role in mass testing and contact tracing efforts, underlining their importance in containing the spread of contagious diseases. Moreover, the development of innovative technologies and the increasing prevalence of chronic diseases, like diabetes and cardiovascular conditions, have led to the creation of diagnostic kits that can provide swift results, facilitating immediate medical interventions and improving patient outcomes.

The global market for rapid medical diagnostic kits encompasses a wide range of products, including pregnancy tests, glucose monitoring kits, infectious disease detection kits, and cancer screening kits, among others. These kits are designed to be user-friendly, requiring minimal training and providing results in a matter of minutes, making them ideal for use in both clinical and non-clinical settings. The market is also driven by the expansion of telemedicine and remote healthcare, which has surged in popularity, especially in the face of the pandemic.

Key Market Drivers

Rising Prevalence of Infectious Diseases

The Global Rapid Medical Diagnostic Kits Market has experienced a significant boost in recent years due to the rising prevalence of infectious diseases. Infectious diseases, caused by viruses, bacteria, and other pathogens, have emerged as a global health concern, with notable outbreaks like the COVID-19 pandemic underscoring the need for rapid and accurate diagnostics. As infectious diseases continue to pose a substantial threat to public health, the demand for diagnostic tools capable of early detection and containment has surged.The COVID-19 pandemic, in particular, has highlighted the critical role that rapid diagnostic kits play in the effective management of infectious diseases. Antigen and antibody tests, known for their quick turnaround time and ease of use, have become pivotal in mass testing efforts and contact tracing, facilitating the swift identification and isolation of infected individuals. This real-world experience has underscored the importance of rapid diagnostic solutions in combating the spread of contagious diseases. The rising prevalence of other infectious diseases, such as influenza, tuberculosis, and sexually transmitted infections, has contributed to the growing demand for rapid diagnostic kits. These diseases can spread quickly and have the potential to cause significant morbidity and mortality if not promptly identified and treated. Rapid diagnostic kits are well-suited for such scenarios, as they enable healthcare providers to obtain test results in a matter of minutes, allowing for immediate medical interventions and public health responses.The need for early and accurate diagnosis is not limited to high-income countries. Low- and middle-income countries with limited access to advanced healthcare infrastructure and laboratories are increasingly relying on rapid diagnostic kits to bridge the gap. These kits can be used in remote and resource-constrained settings, making them an invaluable tool in the global effort to combat infectious diseases and improve healthcare equity.

Technological Advancements

Technological advancements have played a pivotal role in boosting the Global Rapid Medical Diagnostic Kits Market, ushering in a new era of healthcare diagnostics characterized by speed, accuracy, and accessibility. These innovations have revolutionized the landscape of medical diagnostics, making rapid diagnostic kits increasingly sophisticated and effective. Several key technological drivers have propelled the market's growth, transforming the way healthcare professionals diagnose and manage a wide range of medical conditions.One of the most significant technological advancements is the development of nucleic acid amplification tests (NAATs). These tests have greatly enhanced the sensitivity and specificity of diagnostic kits, allowing for the detection of genetic material from pathogens such as viruses and bacteria. NAATs have been instrumental in diagnosing infectious diseases, particularly during the COVID-19 pandemic, where molecular tests like PCR have become the gold standard for diagnosing the virus. These tests provide highly accurate results and have set new benchmarks for rapid diagnostic kit performance.In addition to NAATs, lateral flow assays and immunoassays have undergone substantial technological improvements. These methods use antibodies and antigens to detect specific proteins or antibodies in patient samples, and they have become more precise and reliable due to advancements in the design of detection reagents and materials. Innovations in lateral flow technology have led to increased sensitivity and rapid results, making these assays suitable for point-of-care testing.The integration of microfluidics and lab-on-a-chip technologies is another noteworthy advancement. These technologies allow for the miniaturization and automation of diagnostic processes, reducing the need for extensive laboratory equipment. They enable the development of compact and portable diagnostic kits, which are particularly useful in resource-limited and remote healthcare settings. These innovations empower healthcare providers to perform complex tests with minimal sample volumes, contributing to quicker diagnoses and more efficient healthcare delivery.

Global Aging Population

The Global Rapid Medical Diagnostic Kits Market is experiencing a significant boost due to the global aging population, a demographic shift that has far-reaching implications for healthcare. As the world's elderly population continues to grow, there is a heightened demand for rapid diagnostic kits that can effectively address age-associated health concerns.One of the key drivers of this phenomenon is the increased prevalence of chronic diseases among the elderly. Conditions such as diabetes, cardiovascular diseases, and certain cancers become more common with age. Rapid diagnostic kits play a critical role in the early detection and monitoring of these diseases. They provide a convenient means for the elderly to regularly check their health status, enabling prompt intervention and personalized treatment plans, ultimately leading to better disease management and improved quality of life.The aging population also faces an elevated risk of infections and age-related conditions. Rapid diagnostic kits are indispensable in the early identification of infectious diseases, allowing for timely treatment and reducing the risk of complications in older individuals who may have compromised immune systems. Additionally, certain age-related conditions, like osteoporosis and dementia, can be challenging to diagnose and manage. Diagnostic kits designed for these specific purposes are emerging to cater to the unique healthcare needs of the elderly population. Theelderly individuals often have limited mobility, making it challenging to access healthcare facilities regularly. Rapid diagnostic kits offer a convenient and non-invasive way for them to monitor their health from the comfort of their homes, reducing the burden on both patients and healthcare systems. This trend aligns with the growing preference for home healthcare solutions, which have gained momentum in response to the aging population's needs.

The elderly also frequently face polypharmacy, where they are prescribed multiple medications for various health conditions. Rapid diagnostic kits can help prevent adverse drug interactions and complications by monitoring drug levels and ensuring appropriate dosing. This not only enhances patient safety but also contributes to the efficient management of healthcare resources.

Key Market Challenges

Quality and Accuracy Concerns

The Global Rapid Medical Diagnostic Kits Market has witnessed remarkable growth due to its ability to offer quick and convenient diagnostic solutions. These kits are designed for point-of-care testing, enabling healthcare professionals and patients to obtain rapid results. However, a persistent challenge that hampers the market's progress is the concern over the quality and accuracy of these diagnostic kits.Different rapid diagnostic kits vary in their sensitivity and specificity. Sensitivity refers to a test's ability to correctly identify those with the condition, while specificity is its ability to correctly identify those without the condition. Variability in these parameters can lead to inconsistent results, with some kits providing more accurate results than others.User error in sample collection and handling can affect the accuracy of rapid diagnostic tests. Proper technique is essential to obtain reliable results, but not all users may be well-trained or proficient in executing these steps correctly.Rapid diagnostic kits are often designed to detect specific markers or diseases. This limitation means they may not cover the full spectrum of potential health concerns, missing conditions that are not within the scope of the kit.Some diseases have complex profiles with multiple factors that contribute to their diagnosis. Rapid diagnostic kits may not provide a comprehensive assessment of such diseases, leading to potential inaccuracies.

Cost and Affordability

The Global Rapid Medical Diagnostic Kits Market has witnessed impressive growth, driven by the need for quick and accessible diagnostic solutions. These kits offer the advantage of timely testing and early detection of various medical conditions. However, a significant challenge that hampers the market's broader adoption is the issue of cost and affordability.Rapid medical diagnostic kits often come with a price tag that can be a barrier to accessibility for many individuals and healthcare systems. Healthcare facilities, including hospitals and clinics, need to invest in acquiring a range of diagnostic kits for different medical conditions. The high initial capital required to purchase these kits can deter smaller healthcare providers and those in resource-constrained settings.Rapid diagnostic kits are often disposable, meaning that they need to be restocked regularly. These recurring expenses can add up, increasing the overall cost of diagnostic testing for healthcare providers and patients.In many healthcare systems, the reimbursement for rapid diagnostic tests is not as comprehensive as it is for traditional laboratory-based tests. This discrepancy can dissuade healthcare providers from using rapid kits, especially when the costs are not adequately covered. On the patient's side, the cost of rapid diagnostic tests can be a significant financial burden. Some individuals may forego necessary testing due to the expense, potentially delaying diagnoses, and treatment.

Key Market Trends

Proliferation of Point-of-Care Testing

The proliferation of point-of-care testing is a pivotal trend that has significantly boosted the Global Rapid Medical Diagnostic Kits Market. Point-of-care testing, or POCT, involves conducting medical tests at or near the patient's location, rather than relying on centralized laboratory facilities. This approach has gained tremendous momentum in recent years, transforming the way healthcare is delivered and creating a burgeoning demand for rapid medical diagnostic kits.The convenience and speed offered by point-of-care testing are among the key drivers of its widespread adoption. Rapid diagnostic kits are at the forefront of this trend, enabling healthcare providers to obtain quick results and make immediate treatment decisions. Whether it's in a physician's office, an emergency room, or a remote healthcare clinic, these kits offer on-the-spot diagnoses, reducing the turnaround time and allowing for swift intervention. This is especially critical in situations where timely treatment decisions can save lives, such as during infectious disease outbreaks.Point-of-care testing is particularly valuable in resource-limited and remote settings, where access to centralized laboratories may be limited. These settings benefit immensely from the availability of rapid diagnostic kits, as they provide a practical and efficient means of diagnosing and managing medical conditions without the need for extensive laboratory infrastructure.Moreover, the rise of telemedicine and remote healthcare services has further propelled the demand for rapid diagnostic kits. These kits can be seamlessly integrated into telemedicine platforms, enabling individuals to perform tests in the comfort of their homes and share the results with healthcare providers remotely. This paradigm shift in healthcare delivery aligns with the desire for convenience and accessibility, while also addressing the need for social distancing and reducing the risk of disease transmission, as was particularly evident during the COVID-19 pandemic.

Rapid Cancer Diagnosis

Rapid cancer diagnosis has emerged as a critical driver boosting the Global Rapid Medical Diagnostic Kits Market. The swift and accurate detection of cancer is paramount in improving patient outcomes and treatment success. Rapid diagnostic kits tailored for cancer screening and diagnosis have played an instrumental role in transforming the landscape of cancer care and management.These kits are designed to quickly and efficiently identify specific cancer biomarkers or genetic mutations associated with different types of cancer. They enable healthcare providers to diagnose cancer at an earlier stage, which is often crucial for more successful treatment outcomes. Early cancer detection not only improves the chances of successful treatment but also reduces the overall cost of cancer care by facilitating less invasive and less aggressive treatment options.Rapid cancer diagnostic kits are invaluable in situations where timely diagnosis is essential. Rapid cancer diagnostic kits are used to diagnose cancers that have a rapid progression, such as certain types of blood cancers, as well as to monitor the effectiveness of cancer treatments in real-time. This capability is crucial in adapting treatment strategies, minimizing side effects, and improving patients' quality of life.The market for rapid cancer diagnostic kits continues to evolve, with ongoing technological advancements leading to enhanced sensitivity and specificity. This translates to more accurate and reliable results, reducing the likelihood of false positives or negatives, which can have serious consequences in cancer diagnosis.Moreover, these kits offer a convenient and accessible approach to cancer diagnosis. Patients can often collect samples in non-invasive ways, such as through blood or saliva tests, reducing the discomfort and anxiety associated with traditional cancer diagnostic procedures. This patient-centric approach aligns with the growing trend of personalized medicine, tailoring treatment plans to an individual's unique genetic profile.

Segmental Insights

Application Insights

Based on the Application, Infectious Disease Testing emerged as the dominant segment in the Global Rapid Medical Diagnostic Kits Market in2023.Infectious diseases, including viral and bacterial infections, pose significant and recurrent global health challenges. The ongoing COVID-19 pandemic is a prime example that has underscored the importance of rapid and accurate infectious disease testing. These tests are crucial for diagnosing and controlling the spread of contagious diseases. The world's vulnerability to pandemics has raised awareness of the need for rapid and accessible diagnostic solutions. Infectious disease testing has become a cornerstone in pandemic preparedness, enabling early detection, contact tracing, and containment efforts. Many public health initiatives and vaccination programs rely on infectious disease testing to assess immunity, monitor disease prevalence, and ensure the effectiveness of vaccination campaigns. Rapid diagnostic kits play a pivotal role in these initiatives.

End-use Insights

Based on the End-use, Hospitals emerged as the dominant segment in the Global Rapid Medical Diagnostic Kits Market in 2023.Hospitals are comprehensive healthcare institutions that provide a wide range of medical services, including emergency care, surgeries, specialized treatments, and routine healthcare. They encounter a diverse spectrum of medical conditions and diagnostic needs, necessitating a variety of rapid diagnostic tests. Hospitals deal with complex medical conditions and often require immediate diagnostic results to make critical treatment decisions. Rapid diagnostic kits are essential in an acute care setting, allowing healthcare professionals to quickly assess and respond to medical emergencies and conditions. Hospitals serve both inpatients and outpatients, offering services to individuals with varying healthcare needs. Rapid diagnostic kits are employed in various departments within a hospital, ranging from emergency rooms to intensive care units, inpatient wards, and outpatient clinics.

Regional Insights

North America emerged as the dominant region in the Global Rapid Medical Diagnostic Kits Market in 2023, holding the largest market share. North America boasts a highly developed and advanced healthcare infrastructure, featuring state-of-the-art healthcare facilities, well-equipped laboratories, and a vast network of healthcare providers. This infrastructure is well-suited for the adoption of rapid medical diagnostic kits, allowing for their widespread use in clinical practice. The region is a hub for medical research and technological innovation. North American companies and research institutions are at the forefront of developing cutting-edge diagnostic technologies and solutions, which are then readily integrated into the healthcare system. North America has one of the highest healthcare expenditures in the world. The willingness to invest in healthcare technologies, including rapid diagnostic kits, fuels the growth of the market. Well-funded healthcare systems can afford to adopt the latest diagnostic solutions.

Key Market Players

Artron Laboratories Inc.

Alfa Scientific Designs, Inc.

BD and company

bioMerieux SA

BTNX, Inc.

Bio-Rad Laboratories, Inc.

Danaher Corporation

Cardinal Health Inc,

Creative Diagnostics

F. Hoffmann-La Roche AG

Report Scope:

In this report, the Global Rapid Medical Diagnostic Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rapid Medical Diagnostic Kits Market,By Product:

  • Over the Counter (OTC) Kits
  • Professional Kits

Rapid Medical Diagnostic Kits Market,By Application:

  • Blood Glucose Testing
  • Infectious Disease Testing
  • Cardiometabolic Testing
  • Pregnancy and Fertility Testing
  • Fecal Occult Blood Testing
  • Coagulation Testing
  • Toxicology Testing
  • Lipid Profile Testing
  • Other Applications

Rapid Medical Diagnostic Kits Market,By End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Rapid Medical Diagnostic Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Rapid Medical Diagnostic Kits Market.

Available Customizations:

Global Rapid Medical Diagnostic Kits Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Rapid Medical Diagnostic Kits Market Outlook

  • 4.1.Market Size Forecast
    • 4.1.1.By Value
  • 4.2.Market Share Forecast
    • 4.2.1.By Product (Over the Counter (OTC) Kits, Professional Kits)
    • 4.2.2.By Application (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, Other Applications)
    • 4.2.3.By End-use (Hospitals, Ambulatory Surgical Centers, Others)
    • 4.2.4.By Region
    • 4.2.5.By Company (2023)
  • 4.3.Market Map
    • 4.3.1.By Product
    • 4.3.2.By Application
    • 4.3.3.By End-use
    • 4.3.4.By Region

5.Asia Pacific Rapid Medical Diagnostic Kits Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Product
    • 5.2.2.By Application
    • 5.2.3.By End-use
    • 5.2.4.By Country
  • 5.3.Asia Pacific: Country Analysis
    • 5.3.1.China Rapid Medical Diagnostic Kits Market Outlook
      • 5.3.1.1.Market Size Forecast
        • 5.3.1.1.1.By Value
      • 5.3.1.2.Market Share Forecast
        • 5.3.1.2.1.By Product
        • 5.3.1.2.2.By Application
        • 5.3.1.2.3.By End-use
    • 5.3.2.India Rapid Medical Diagnostic Kits Market Outlook
      • 5.3.2.1.Market Size Forecast
        • 5.3.2.1.1.By Value
      • 5.3.2.2.Market Share Forecast
        • 5.3.2.2.1.By Product
        • 5.3.2.2.2.By Application
        • 5.3.2.2.3.By End-use
    • 5.3.3.Australia Rapid Medical Diagnostic Kits Market Outlook
      • 5.3.3.1.Market Size Forecast
        • 5.3.3.1.1.By Value
      • 5.3.3.2.Market Share Forecast
        • 5.3.3.2.1.By Product
        • 5.3.3.2.2.By Application
        • 5.3.3.2.3.By End-use
    • 5.3.4.Japan Rapid Medical Diagnostic Kits Market Outlook
      • 5.3.4.1.Market Size Forecast
        • 5.3.4.1.1.By Value
      • 5.3.4.2.Market Share Forecast
        • 5.3.4.2.1.By Product
        • 5.3.4.2.2.By Application
        • 5.3.4.2.3.By End-use
    • 5.3.5.South Korea Rapid Medical Diagnostic Kits Market Outlook
      • 5.3.5.1.Market Size Forecast
        • 5.3.5.1.1.By Value
      • 5.3.5.2.Market Share Forecast
        • 5.3.5.2.1.By Product
        • 5.3.5.2.2.By Application
        • 5.3.5.2.3.By End-use

6.Europe Rapid Medical Diagnostic Kits Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Product
    • 6.2.2.By Application
    • 6.2.3.By End-use
    • 6.2.4.By Country
  • 6.3.Europe: Country Analysis
    • 6.3.1.France Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Product
        • 6.3.1.2.2.By Application
        • 6.3.1.2.3.By End-use
    • 6.3.2.Germany Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Product
        • 6.3.2.2.2.By Application
        • 6.3.2.2.3.By End-use
    • 6.3.3.Spain Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Product
        • 6.3.3.2.2.By Application
        • 6.3.3.2.3.By End-use
    • 6.3.4.Italy Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.4.1.Market Size Forecast
        • 6.3.4.1.1.By Value
      • 6.3.4.2.Market Share Forecast
        • 6.3.4.2.1.By Product
        • 6.3.4.2.2.By Application
        • 6.3.4.2.3.By End-use
    • 6.3.5.United Kingdom Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.5.1.Market Size Forecast
        • 6.3.5.1.1.By Value
      • 6.3.5.2.Market Share Forecast
        • 6.3.5.2.1.By Product
        • 6.3.5.2.2.By Application
        • 6.3.5.2.3.By End-use

7.North America Rapid Medical Diagnostic Kits Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Product
    • 7.2.2.By Application
    • 7.2.3.By End-use
    • 7.2.4.By Country
  • 7.3.North America: Country Analysis
    • 7.3.1.United States Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Product
        • 7.3.1.2.2.By Application
        • 7.3.1.2.3.By End-use
    • 7.3.2.Mexico Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Product
        • 7.3.2.2.2.By Application
        • 7.3.2.2.3.By End-use
    • 7.3.3.Canada Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Product
        • 7.3.3.2.2.By Application
        • 7.3.3.2.3.By End-use

8.South America Rapid Medical Diagnostic Kits Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Product
    • 8.2.2.By Application
    • 8.2.3.By End-use
    • 8.2.4.By Country
  • 8.3.South America: Country Analysis
    • 8.3.1.Brazil Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Product
        • 8.3.1.2.2.By Application
        • 8.3.1.2.3.By End-use
    • 8.3.2.Argentina Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Product
        • 8.3.2.2.2.By Application
        • 8.3.2.2.3.By End-use
    • 8.3.3.Colombia Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Product
        • 8.3.3.2.2.By Application
        • 8.3.3.2.3.By End-use

9.Middle East and Africa Rapid Medical Diagnostic Kits Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Product
    • 9.2.2.By Application
    • 9.2.3.By End-use
    • 9.2.4.By Country
  • 9.3.MEA: Country Analysis
    • 9.3.1.South Africa Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Product
        • 9.3.1.2.2.By Application
        • 9.3.1.2.3.By End-use
    • 9.3.2.Saudi Arabia Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Product
        • 9.3.2.2.2.By Application
        • 9.3.2.2.3.By End-use
    • 9.3.3.UAE Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Product
        • 9.3.3.2.2.By Application
        • 9.3.3.2.3.By End-use
    • 9.3.4.Egypt Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.4.1.Market Size Forecast
        • 9.3.4.1.1.By Value
      • 9.3.4.2.Market Share Forecast
        • 9.3.4.2.1.By Product
        • 9.3.4.2.2.By Application
        • 9.3.4.2.3.By End-use

10.Market Dynamics

  • 10.1.Drivers
  • 10.2.Challenges

11.Market Trends Developments

  • 11.1.Recent Developments
  • 11.2.Application Launches
  • 11.3.Mergers Acquisitions

12.Global Rapid Medical Diagnostic Kits Market: SWOT Analysis

13.Porter's Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Product

14.Competitive Landscape

  • 14.1.Artron Laboratories Inc.
    • 14.1.1.Business Overview
    • 14.1.2.Company Snapshot
    • 14.1.3.Products Services
    • 14.1.4.Financials (In case of listed)
    • 14.1.5.Recent Developments
    • 14.1.6.SWOT Analysis
  • 14.2.Alfa Scientific Designs, Inc.
  • 14.3.BD and company
  • 14.4.bioMerieux SA
  • 14.5.BTNX, Inc.
  • 14.6.Bio-Rad Laboratories, Inc.
  • 14.7.Danaher Corporation
  • 14.8.Cardinal Health Inc.
  • 14.9.Creative Diagnostics
  • 14.10.F. Hoffmann-La Roche AG

15.Strategic Recommendations

16.About Us Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제